Jones Lang LaSalle holds the cleaner structural position, with the lead spread across valuation and profitability. CVS Health still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, CVS Health carries the stronger setup — intact trend against Jones Lang LaSalle's broken trend. That leaves a split case: the structural lead stays with Jones Lang LaSalle, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The clearest separation starts in valuation, but profitability adds another real layer to the result. Jones Lang LaSalle Incorporated leads by 20 points on the overall comparison score.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
Most of the shared profile comes through investment intensity and margin consistency.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Jones Lang LaSalle Incorporated and CVS Health Corporation look relatively close on structure, but the price setup still leans toward Jones Lang LaSalle Incorporated.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Where CVS and JLL each sit in their own 5-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
The multiple-based pricing edge comes from a trailing P/E that is 27 turns lower.
CVS Health Corporation still looks less cycle-sensitive — that keeps the result from looking completely one-sided.
The lead is built on both valuation and profitability — though stability still provides a counterweight.
Break down the CVS vs JLL comparison across all dimensions with the full interactive tool.
Explore how CVS and JLL each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.